The impact of COVID‐19 on new mesothelioma diagnoses in Italy

Thoracic Cancer

ReNaM Working Group¹  Guido Mazzoleni²  Federico Tallarigo³  Antonio Romanelli⁴  Corrado Negro⁵  Lucia Benfatto⁶  Carolina Mensi⁷  Iolanda Grappasonni⁸  Enrica Migliore⁹  Domenica Cavone^1,10  Rosario Tumino^1,11  Elisabetta Chellini^1,12  Veronica Casotto^1,13  Alessandro Marinaccio^1,14  Pamela Mancuso^1,15  Isabella Bisceglia^1,15  Lucia Mangone^1,15  Paolo Giorgi Rossi^1,15 

[1] ;COR Alto‐Adige, Health Trust South Tyrol South Tyrol Italy;COR Calabria, c/o UOC Anatomia Patologica PO San Giovanni di Dio, ASP Crotone Italy;COR Emilia‐Romagna, Epidemiology Unit Azienda Unità Sanitaria Locale – IRCCS di Reggio Emilia Reggio Emilia Italy;COR Friuli Venezia Giulia Azienda Ospedaliero‐Universitaria “Ospedali Riuniti di Trieste” Struttura Complessa Medicina del Lavoro Trieste Italy;COR Liguria, Epidemiologia Clinica Istituto Nazionale per la Ricerca sul Cancro (IST‐Nord), Dipartimento Terapie Oncologiche Integrate e IRCCS Azienda Ospedaliera Universitaria San Martino Genoa Italy;COR Lombardia, Occupational Health Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy;COR Marche, School of Medicinal and Health Products Sciences University of Camerino Camerino Italy;COR Piemonte Unità di Epidemiologia dei Tumori Città della salute e della scienza di Torino Torino Italy;COR Puglia, Interdisciplinary Department of Medicine, Section Occupational Medicine B. Ramazzini, School of Medicine University Aldo Moro Bari Bari Italy;COR Sicilia, Cancer Registry and Histopathology Department Provincial Health Authority (ASP 7) Ragusa Italy;COR Toscana, Unit of Occupational & Environmental Epidemiology Institute for Cancer Research, Prevention and Clinical Network Firenze Italy;COR Veneto, Epidemiological Department, Azienda Zero, Veneto Region Padova Italy;RENAM, INAIL (Italian Workers' Compensation Authority) Occupational and Environmental Medicine, Epidemiology and Hygiene Department, Occupational and Environmental Epidemiology Unit Rome Italy;Reggio Emilia Cancer Registry, Epidemiology Unit Azienda Unità Sanitaria Locale – IRCCS di Reggio Emilia Reggio Emilia Italy;

关键词: COVID‐19;    incidence;    mesothelioma;   

DOI  :  10.1111/1759-7714.14296

来源: DOAJ

【 摘 要 】

Abstract Background The aim of this work was to evaluate the impact of the restrictions put in place to control the COVID‐19 pandemic on new diagnoses of malignant mesothelioma (MM) in Italy. Methods Twelve of the 21 Italian malignant mesothelioma CORs (regional operating centres) participated. The study included all cases of MM with microscopic confirmation; cases without microscopic confirmation and death certificate only (DCO) were excluded. For each case, information on sex, date of birth, tumor site, morphology, and date of diagnosis was retrieved. We compared the number of incident cases in 2020 with 2019, looking at the overall picture and for four periods: pre‐pandemic (January–February), first wave (March–May), low incidence (June–September), and second wave (October–December). Results A total of 604 cases were registered: 307 in 2019 and 297 in 2020. In the 2020 pre‐pandemic period, the incidence was higher than in the same months in 2019 (+45%); there was no significant change during the first wave (+1%) or in the low‐incidence period (−3%), while a decrease was observed during the second wave (−32%). However, the data were not homogeneous across the country: the increase in the pre‐pandemic period concerned mostly the regions of northern (+61.5%) and central Italy (+43.5%); during the first wave, MM diagnoses increased in the northern (+38.5%) and central (+11.4%) regions but decreased in the southern regions (−52.9%). All these differences are compatible with random fluctuations. Conclusion The COVID‐19 pandemic had little or no impact on new MM diagnoses, and variations were not homogeneous throughout the country.

【 授权许可】

Unknown